These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 2119464)

  • 1. [3-dimensional imaging of regional cerebral blood flow by means of emission computed tomography].
    Higano S; Uemura K; Kanno I
    Nihon Rinsho; 1990 Jul; 48(7):1591-8. PubMed ID: 2119464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of cerebral circulation by SPECT].
    Matsuda H
    No Shinkei Geka; 1993 Feb; 21(2):111-8. PubMed ID: 8459897
    [No Abstract]   [Full Text] [Related]  

  • 3. Mapping cerebral blood flow.
    Ell PJ
    J Nucl Med; 1992 Oct; 33(10):1843-5. PubMed ID: 1403154
    [No Abstract]   [Full Text] [Related]  

  • 4. What does rCBF-SPECT offer in schizophrenia?
    Syed GM; Barrett JJ; Toone BK
    Nucl Med Commun; 1992 Dec; 13(12):879-84. PubMed ID: 1465271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain SPECT imaging and psychiatry.
    Van Heertum RL
    J Clin Psychiatry; 1992 Nov; 53 Suppl():7-12. PubMed ID: 1459983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral blood flow imaging in patients with brain tumor and arterio-venous malformation using Tc-99m hexamethylpropylene-amine oxime--a comparison with Xe-133 and IMP].
    Hoshi H; Jinnouchi S; Watanabe K; Onishi T; Uwada O; Nakano S; Kinoshita K
    Kaku Igaku; 1987 Nov; 24(11):1617-23. PubMed ID: 3502279
    [No Abstract]   [Full Text] [Related]  

  • 7. [99mTc-hexamethyl-propyleneamine oxime cerebral perfusion SPECT in patients with cerebrovascular disease].
    Jinnouchi S; Hoshi H; Yoshimura H; Nagamachi S; Ohnishi T; Uwada O; Futami S; Watanabe K; Nakano S; Kinoshita K
    Kaku Igaku; 1988 Jan; 25(1):31-8. PubMed ID: 3259643
    [No Abstract]   [Full Text] [Related]  

  • 8. [The usefulness of single photon emission computed tomography using N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-hexamethylpropyleneamine oxime in patients with moyamoya disease].
    Morita K; Ono S; Fukunaga M; Otsuka N; Nagai K; Furukawa T; Muranaka A; Mimura H; Yanagimoto S; Tomomitsu T
    Kaku Igaku; 1990 Jan; 27(1):69-80. PubMed ID: 2338770
    [No Abstract]   [Full Text] [Related]  

  • 9. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease.
    Ell PJ; Hocknell JM; Jarritt PH; Cullum I; Lui D; Campos-Costa D; Nowotnik DP; Pickett RD; Canning LR; Neirinckx RD
    Nucl Med Commun; 1985 Aug; 6(8):437-41. PubMed ID: 3877889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of crossed cerebellar diaschisis after convulsion in a patient with a putaminal hemorrhage.
    Katsuragi M; Torigoe R; Nishihara H
    Clin Nucl Med; 1994 Jul; 19(7):651-2. PubMed ID: 7924115
    [No Abstract]   [Full Text] [Related]  

  • 11. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
    Tsuchida T; Nishizawa S; Yonekura Y; Sadato N; Iwasaki Y; Fujita T; Matoba N; Magata Y; Tamaki N; Konishi J
    J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of brain perfusion SPECT imaging to dementia].
    Matsuda H
    Rinsho Hoshasen; 1989 Oct; 34(11):1327-35. PubMed ID: 2601094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward absolute quantitation of cerebral blood flow using technetium-99m-HMPAO and a single scan.
    Rattner Z; Smith EO; Woods S; Dey H; Hoffer PB
    J Nucl Med; 1991 Aug; 32(8):1506-7. PubMed ID: 1869969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral perfusion SPECT using Tc-99m-d,l-HMPAO: comparative study with I-123 IMP and CBF measured by PET].
    Nishizawa S; Yonekura Y; Fujita T; Senda M; Konishi J; Ishikawa M; Fukuyama H
    Kaku Igaku; 1987 Oct; 24(10):1521-8. PubMed ID: 3502007
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonlinearity correction of brain perfusion SPECT based on permeability-surface area product model.
    Tsuchida T; Yonekura Y; Nishizawa S; Sadato N; Tamaki N; Fujita T; Magata Y; Konishi J
    J Nucl Med; 1996 Jul; 37(7):1237-41. PubMed ID: 8965204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO.
    Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
    J Nucl Med; 1989 Feb; 30(2):157-64. PubMed ID: 2786931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT?
    Hayashida K; Nishimura T; Imakita S; Uehara T
    Neuroradiology; 1990; 32(3):196-9. PubMed ID: 2215903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Several perfusion studies.
    Merrick MV
    Eur J Nucl Med; 1990; 17(1-2):98-9. PubMed ID: 2083551
    [No Abstract]   [Full Text] [Related]  

  • 19. Double tracer autoradiographic method for sequential evaluation of regional cerebral perfusion.
    Matsuda H; Tsuji S; Oba H; Kinuya K; Terada H; Sumiya H; Shiba K; Mori H; Hisada K; Maeda T
    Am J Physiol Imaging; 1989; 4(4):131-5. PubMed ID: 2624815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radionuclide studies of atherosclerosis].
    Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Inoue Y; Kashimada A; Osada H
    Nihon Rinsho; 1993 Aug; 51(8):2060-5. PubMed ID: 8411672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.